LncRNA OXCT1-AS1 can block NARF-mediated ubiquitination to stabilize LEF1 and thereby promote the ability of NSCLC to metastasize, which suggests that lncRNA OXCT1-AS1 is a new therapeutic target for NSCLC (56). This evidence concerns the gene NARF and non-small cell lung carcinoma.